Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
29 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsGenmab Announces European Marketing Authorization for DARZALEX® (daratumumab) for Relapsed or Refractory Multiple Myeloma
(WorldNews Denmark)

 
 

28 april 2017 14:19:09

 
Genmab Announces European Marketing Authorization for DARZALEX® (daratumumab) for Relapsed or Refractory Multiple Myeloma
(WorldNews Denmark)
 


Company Announcement DARZALEX approved in Europe in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone in patients who have received at least one prior therapy Genmab to receive milestone payments totaling USD 48 million from Janssen upon the first sale of DARZALEX in the newly approved indications Copenhagen, Denmark; April 28, 2017 -Genmab A/S (Nasdaq Copenhagen: GEN) announced today that the European Commission (EC) has granted a marketing authorization for DARZALEX (daratumumab) in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior...


 
24 viewsCategory: General > Europe > Denmark
 
Ascendis Pharma A/S Announces Upcoming Investor Presentations
(WorldNews Denmark)
How to calculate dehumidification needs in indoor pools?
(WorldNews Denmark)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten